mdlinx mdlinx
Latest (26) Full Text Articles (3243) Focus on CAD Article Summary

Warfarin Dose Assessment Every 4 Weeks Versus Every 12 Weeks in Patients With Stable International Normalized Ratios Full Text
Annals of Internal Medicine, 11/18/2011  Clinical Article

Schulman S et al. – Assessment of warfarin dosing every 12 weeks seems to be safe and noninferior to assessment every 4 weeks. A comparison of international normalized ratio (INR) testing, patient contact, and warfarin dose assessment every 12 weeks versus every 4 weeks is necessary before INR testing every 12 weeks can be routinely recommended for practice.

Methods
  • Noninferiority randomized trial.
  • The randomization schedule (in a 1:1 ratio) was computer–generated, and allocation was concealed until the database was locked by using a centralized schedule.
  • Patients, study and clinical personnel, adjudicators of clinical events, and the study statistician were blinded to treatment assignment.
  • Single center in Hamilton, Ontario, Canada.
  • 250 patients receiving long–term warfarin therapy, whose dose was unchanged for at least 6 months; 226 completed the study.
  • Dosing assessment every 12 weeks (n = 124) compared with every 4 weeks (n = 126) for 12 months.
  • Patients in the 12–week group were tested every 4 weeks; sham INRs within the target range were reported for two of the three 4–week periods.
  • Percentage of time in the therapeutic range (primary outcome) and number of extreme INRs, changes in maintenance dose, major bleeding events, objectively verified thromboembolism, and death (secondary outcomes).

Results
  • The percentage of time in the therapeutic range was 74.1% (SD, 18.8%) in the 4–week group compared with 71.6% (SD, 20.0%) in the 12–week group (absolute difference, 2.5 percentage points [1–sided 97.5% upper confidence bound, 7.3 percentage points]; noninferiority P = 0.020 for a 7.5–percentage point margin).
  • Fewer patients in the 12–week group than in the 4–week group had any dose changes (37.1% vs. 55.6%; absolute difference, 18.5 percentage points [95% CI, 6.1 to 30.0 percentage points]; P = 0.004).
  • Secondary outcomes did not differ between groups.

► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Cardiology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Cardiology Articles

Last month's top read Top Articles of 2012

1 Effect of Metoprolol Versus Carvedilol on Outcomes in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy) JACC - Journal of the American College of Cardiology, April 3, 2013    Clinical Article

2 Rate versus rhythm control for management of atrial fibrillation in clinical practice: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry American Heart Journal, April 1, 2013    Clinical Article

3 The long QT syndrome: a transatlantic clinical approach to diagnosis and therapy European Heart Journal, April 9, 2013    Review Article    Clinical Article

4 Effect of coenzyme q10 supplementation on statin-induced myalgias The American Journal of Cardiology, July 30, 2012    Clinical Article

5 Chlorthalidone Versus Hydrochlorothiazide for the Treatment of Hypertension in Older Adults A Population-Based Cohort Study Annals of Internal Medicine, March 19, 2013    Clinical Article

6 Statins and autoimmunity Immunologic Research, April 17, 2013    Review Article    Clinical Article

7 Meta-Analysis of Carvedilol Versus Beta 1 Selective Beta-Blockers (Atenolol, Bisoprolol, Metoprolol, and Nebivolol) The American Journal of Cardiology, February 26, 2013    Evidence Based Medicine    Review Article    Clinical Article

8 Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial The Lancet, April 18, 2013    Clinical Article

9 Clinical Update on the Management of Atrial Fibrillation Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, April 10, 2013    Clinical Article

10 Treatment of Hypertension Among African Americans: The Jackson Heart Study The Journal of Clinical Hypertension, April 5, 2013    Clinical Article

11 Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial European Heart Journal, April 22, 2013    Clinical Article

12 Pulmonary hypertension: diagnosis and management British Medical Journal, April 23, 2013    Continuing Medical Education    Review Article

13 Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials British Medical Journal, April 25, 2013    Evidence Based Medicine    Review Article

14 Infective Endocarditis New England Journal of Medicine, April 24, 2013    Continuing Medical Education    Review Article

15 Novel oral anticoagulants for stroke prevention in atrial fibrillation: a focus on the older patient Full Text International Journal of General Medicine, April 2, 2013    Free full text    Clinical Article

16 Comparison of Prasugrel and Ticagrelor Loading Doses in ST-Segment Elevation Myocardial Infarction Patients RAPID (Rapid Activity of Platelet Inhibitor Drugs) Primary PCI Study JACC - Journal of the American College of Cardiology, April 12, 2013    Clinical Article

17 Combination therapy in the management of pulmonary arterial hypertension International Journal of Clinical Practice, April 15, 2013    Review Article

18 A double-blind, double-dummy, randomized, placebo-controlled trial to evaluate the effect of statin therapy on triglyceride levels in Mexican hypertriglyceridemic patients Current Medical Research and Opinion, April 16, 2013    Clinical Article

19 Long-term clinical follow-up of the multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: Cortisone plus BMS or DES veRsus BMS alone to EliminAte Restenosis (CEREA-DES) European Heart Journal, April 11, 2013    Clinical Article

20 Can Vitamin D Supplementation Improve the Severity of Congestive Heart Failure? Full Text Congestive Heart Failure, April 2, 2013    Free full text    Clinical Article

Indexed Journals in Cardiology: American Heart Journal, American Journal of Cardiology, Circulationn, Heartmore

Other Topics in Cardiology

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close